← All candidates
No insider filings on record.
6 filings on record.
AUTLAutolus Therapeutics plc
NasdaqGS · Healthcare · $505.71M
$1.89
-2.58% · Sep 15
No insider filings on record.
Autolus Therapeutics plc hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · 1 move explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$505.71M
Float
102.9M
39% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
4.3
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
No insider transactions on file for AUTL yet.
Context
Wall St
$8.73 avg target
+361.6% vs today · 8 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q2 '26−$0.15 act+$0.04
Q1 '26−$0.27 act−$0.01
Q4 '25−$0.34 act−$0.07
Q3 '25−$0.30 act−$0.07
The file stays open
6 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice